- >=99.0 HPLCHPLC / MSIn stock
Research compound
CJC no DAC
CJC no DAC (Modified GRF 1-29) is a 29-amino acid GHRH analog, modified at positions 2, 8, 15, and 27 to resist dipeptidyl peptidase IV cleavage. It binds the GHRH receptor on pituitary somatotrophs and activates adenylate cyclase via Gs-protein coupling, producing a characterized cAMP elevation in cell culture. Without the drug affinity complex, assay half-life is substantially reduced relative to CJC-1295 with DAC, defining its role in pulse-mode receptor stimulation protocols where time-limited receptor engagement is the experimental parameter. For laboratory research use only.
Specification
- CAS
- 446036-97-1
- Molecular weight
- 3367.9 g/mol
- Formula
- C152H252N44O42
- Purity
- >=99.0 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is CJC no DAC?
CJC no DAC is a synthetic research compound studied in laboratory settings. It has molecular formula C152H252N44O42, a molecular weight of 3367.9 g/mol, CAS 446036-97-1. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's CJC no DAC?
Valitec Peptides supplies CJC no DAC at >=99.0% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is CJC no DAC supplied?
CJC no DAC is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.